MedPath

A Study to Evaluate the Effect of Spinal Cord Stimulation (SCS) on Painful Diabetic Peripheral Neuropathy (pDPN)

Not Applicable
Active, not recruiting
Conditions
Chronic Pain
Interventions
Device: Spinal Cord Stimulation (SCS)
Registration Number
NCT05302063
Lead Sponsor
Boston Scientific Corporation
Brief Summary

The purpose of the study is to evaluate the effects of stimulation parameters on clinical outcomes of Spinal Cord Stimulation (SCS) in the treatment of chronic, intractable limb pain resulting from painful Diabetic Peripheral Neuropathy (pDPN).

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
28
Inclusion Criteria
  • Clinical diagnosis of diabetes mellitus, according to International Diabetes guidelines.
  • Willing and able to comply with all protocol-required procedures and assessments/evaluations.
  • Eligible candidate for SCS from a surgical, cognitive, psychological and psychiatric standpoint per site's routine screening process and based on investigator judgement.
  • Subject signed a valid, EC-approved informed consent form (ICF) provided in local language.

Key

Exclusion Criteria
  • Primary etiology for lower limb neuropathic pain not due to Diabetic Peripheral Neuropathy (DPN).
  • Participating (or intends to participate) in another drug or device clinical trial that may influence the data that will be collected for this study.
  • Currently implanted with an active implantable device(s) (e.g., pacemaker, drug pump).
  • A female who is pregnant, lactating, or is of childbearing potential and planning to get pregnant during the study or not using adequate contraception.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Spinal Cord Stimulation (SCS)Spinal Cord Stimulation (SCS)Boston Scientific Spinal Cord Stimulation Systems with multiple modalities
Primary Outcome Measures
NameTimeMethod
Pain Relief in Limb PainUp to 12 months follow up

Percent Pain Relief (PPR) in limb pain using a questionnaire where 100% is complete relief and 0% is no relief in pain compared with Baseline

Secondary Outcome Measures
NameTimeMethod
Global Impression of ChangeUp to 12 months follow up

Patient global impression of change (PGI-C) at 3-, 6- and 12-Month Assessment Visit where patients use a seven-point scale to assess how much their condition has improved or worsened relative to their baseline. Subjects will rate themselves as: very much improved; much improved; minimally improved; no change; minimally worse; much worse; or very much worse.

Trial Locations

Locations (1)

Hospital La Paz

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath